Search:

Login | Subscribe

Home > Companies > Phynova

Price	Market	Sector	Market Cap
12.00p (0.00p) 0.00%	AIM	Medicine and Biotech Research	£2.71m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
AZH	p
BBI	p
CEN	p
CBF	2.25p	0.00%
COT	93.00p	0.54%
CRX	2.75p	0.00%
CYX	p
LAC	p
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	29.00p	7.41%
GMX	1.75p	0.00%
GNI	p
GWP	30.00p	3.45%
HML	0.42p	0.00%
MLR	p
MMG	7.25p	0.00%
MPM	14.25p	0.00%

Commentary

Developer of prescription pharmaceuticals derived from Chinese botanical medicines

Recent Articles

Phynova hails pre-clinical cheer	22/10/2008
Phynova	02/04/2008
Magical minnows	01/05/2007
Phynova Group	16/05/2006
Newcomer - Phynova	27/02/2006

Recent Announcements

Correction: Director's Declaration	26/11/2008
Statement re Director's declaration	25/11/2008
PHYNOVA ANNOUNCES COLLABORATION WITH NORGINE	18/11/2008
Phynova's Anti-MRSA Candidate PYN6 Announcment	21/10/2008
Directorate Change	22/09/2008
NOTIFICATION OF PATENT ALLOWA	08/07/2008
Interim Results	27/06/2008
Phynova presents data relatin	30/05/2008
Change of Advisers	29/05/2008
Result of AGM	30/04/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	30/09/2005	30/09/2006	30/09/2007
Currency	GBP	GBP	GBP
Turnover	0.00	0.00	0.00
Operating Profit	-0.61	-1.66	-2.97
Pretax Profit	-0.61	-1.64	-2.95
Earnings After Tax	-0.61	-1.64	-2.85
Profit Available For Dividend	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00
Retained Profit	-0.61	-1.64	-2.85
Shareholders Funds	-0.22	1.66	1.67
Net Current Assets	0.02	2.03	1.47
Adjusted Earnings Per Share Undiluted	-8.70	-13.60	-15.10
Adj Earnings Per Share	-8.70	-13.60	-15.10
Dividend Per Share	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	Phynova House, 16 Fenlock Court, Blenheim Office Park, Long Hanborough, 0X29 8LN
Telephone	01993 880 700
Fax	01993 886 687
Executives
Chairman	Karl Watkin (0.50% holding)
Chief Executive	Tony Mills (0.10% holding)
Finance Director	Michael Martin (0.00% holding)
Director	Stephen Marshall (5.90% holding)
Main Shareholders
	Charles Anderson: 10% Graeme Spiers: 8.2% William Doyle: 7.6% Michael Martin: 4.7%
Advisers
Nominated Adviser	John East & Partners
Nominated Broker	Evolution Securities
Solicitors	Osborne Clarke
Auditors	BDO Stoy Hayward
Registrar	Capita Registrars

Commentary
Developer of prescription pharmaceuticals derived from Chinese botanical medicines
Company Data
Code	PYN
Sedol	GB00B0YBCM
Shares In Issue	22.570 m
Indices
Entry on AIM	27/02/2006
Interim Results	Jun
Final Results	Mar
Year End	Sep
Accounts Due	Mar
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief	Yes